NIH-funded research R21 grant

Understanding how protein modifications affect skin cell function in fibrosis

Official title: The role of protein O-GlcNAcylation in regulating keratinocyte function in skin fibrosis

Funded at Cleveland Clinic Lerner Com-Cwru · NIH-10725270 · Data updated 2026-11-12

This study is looking at how a specific protein affects skin cells and their communication with other cells that help make collagen, to find better ways to treat skin fibrosis in people with localized scleroderma.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionCleveland Clinic Lerner Com-Cwru
NIH-funded
Lab location1 site (Cleveland, United States)
Project startSeptember 23, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$401,433
NIH project number1R21AR082999-01
Project IDNIH-10725270 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with localized scleroderma or those experiencing skin fibrosis.

Less likely to help

Patients with conditions unrelated to skin fibrosis or localized scleroderma may not benefit from this research.

What this research studies

This research investigates the role of protein O-GlcNAcylation in keratinocytes, which are the primary cells in the outer layer of the skin, and how this process influences skin fibrosis, particularly in localized scleroderma. The study aims to uncover the mechanisms by which keratinocytes communicate with fibroblasts, the cells responsible for collagen production, to better understand the disease progression. By exploring these cellular interactions, the research seeks to identify potential therapeutic targets for improving treatment outcomes for patients suffering from skin fibrosis.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for patients with localized scleroderma and related fibrotic conditions.

How similar studies have gone: While the specific approach of targeting protein O-GlcNAcylation in keratinocytes is relatively novel, similar studies have shown promise in understanding fibrotic diseases.

Where this research is happening

  • Cleveland Clinic Lerner Com-Cwru
    Cleveland, United States
    Active

Researchers

  • Principal investigator: Wang, Yan — Cleveland Clinic Lerner Com-Cwru
  • Study coordinator: Wang, Yan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.